Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic
- Status
- COMPLETED
- Phase
- PHASE3